| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors
|
Liu, Yiqian
|
|
|
85 |
5 |
p. 907-915
|
artikel
|
| 2 |
A phase I study of the effect of repeated oral doses of pantoprazole on the pharmacokinetics of a single dose of fedratinib in healthy male subjects
|
Ogasawara, Ken
|
|
|
85 |
5 |
p. 995-1001
|
artikel
|
| 3 |
Assessment of pharmacokinetic variations of capecitabine after multiple administration in rats: a physiologically based pharmacokinetic model
|
Sakai, Shuhei
|
|
|
85 |
5 |
p. 869-880
|
artikel
|
| 4 |
Cerebrospinal fluid penetration of the colony-stimulating factor-1 receptor (CSF-1R) inhibitor, pexidartinib
|
Shankarappa, Priya S.
|
|
|
85 |
5 |
p. 1003-1007
|
artikel
|
| 5 |
Clinical pharmacokinetics and pharmacodynamics of ivosidenib in patients with advanced hematologic malignancies with an IDH1 mutation
|
Fan, Bin
|
|
|
85 |
5 |
p. 959-968
|
artikel
|
| 6 |
Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer
|
Babiker, Hani M.
|
|
|
85 |
5 |
p. 1009-1010
|
artikel
|
| 7 |
Docetaxel dose-intensity effect on overall survival in patients with metastatic castrate-sensitive prostate cancer
|
Kushnir, Igal
|
|
|
85 |
5 |
p. 863-868
|
artikel
|
| 8 |
Effects of repeated oral doses of ketoconazole on a sequential ascending single oral dose of fedratinib in healthy subjects
|
Ogasawara, Ken
|
|
|
85 |
5 |
p. 899-906
|
artikel
|
| 9 |
Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer
|
Shoji, Tetsuaki
|
|
|
85 |
5 |
p. 843-853
|
artikel
|
| 10 |
Inhibition of cyclin-dependent kinases by AT7519 enhances nasopharyngeal carcinoma cell response to chemotherapy
|
Wei, Xin
|
|
|
85 |
5 |
p. 949-957
|
artikel
|
| 11 |
Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors
|
Coyne, Geraldine O.’Sullivan
|
|
|
85 |
5 |
p. 979-993
|
artikel
|
| 12 |
Pharmacokinetics and pharmacogenetics of high-dose methotrexate in Chinese adult patients with non-Hodgkin lymphoma: a population analysis
|
Yang, Lin
|
|
|
85 |
5 |
p. 881-897
|
artikel
|
| 13 |
Pharmacokinetics of polatuzumab vedotin in combination with R/G-CHP in patients with B-cell non-Hodgkin lymphoma
|
Shemesh, Colby S.
|
|
|
85 |
5 |
p. 831-842
|
artikel
|
| 14 |
Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer
|
Huijberts, Sanne C. F. A.
|
|
|
85 |
5 |
p. 917-930
|
artikel
|
| 15 |
Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors
|
Kawazoe, Akihito
|
|
|
85 |
5 |
p. 855-862
|
artikel
|
| 16 |
Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine
|
Soyama, Hiroaki
|
|
|
85 |
5 |
p. 941-947
|
artikel
|
| 17 |
Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study
|
Mammatas, L. H.
|
|
|
85 |
5 |
p. 931-940
|
artikel
|
| 18 |
The influence of PD-L1 genetic variation on the prognosis of R0 resection colorectal cancer patients received capecitabine-based adjuvant chemotherapy: a long-term follow-up, real-world retrospective study
|
Su, Jinsong
|
|
|
85 |
5 |
p. 969-978
|
artikel
|
Tijdschrift beschrijving